The synthesis review of the approved Tyrosine kinase inhibitors for anticancer therapy in 2015-2020
2021
In the 21st century, cancer is the major public health problem worldwide. Based on the important roles of protein tyrosine kinase, the accelerated hunt for potent small-molecule tyrosine kinase inhibitors has led to the success of 30 newly inhibitors in this family for the cancer therapy in last five years. In this review, we updated their synthesis methods, and compared the original research routes with the optimized routes for each PTK inhibitor against different target, in order to make an outlook on the future synthesis of potential PTK inhibitors for anticancer therapy.
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
96
References
4
Citations
NaN
KQI